Interestingly, in a company announcement (Investor Briefing Update presentation slide 25 - 6/6/2013), Nexus specifically stated that there was quote:
"No need to raise equity to satisfy short term funding over next 12 months with focus on dual-track asset divestment process to provide medium term funding"
- Forums
- ASX - By Stock
- Three items of interest
NXS
next science limited
Add to My Watchlist
0.00%
!
13.5¢

Interestingly, in a company announcement (Investor Briefing...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.44M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.5¢ | $107.1K | 794.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21585 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 540090 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 21585 | 0.135 |
16 | 3623138 | 0.130 |
8 | 1454180 | 0.125 |
3 | 845000 | 0.120 |
7 | 980800 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 540090 | 5 |
0.145 | 198817 | 5 |
0.150 | 1146000 | 7 |
0.155 | 807692 | 3 |
0.160 | 243164 | 4 |
Last trade - 10.21am 07/07/2025 (20 minute delay) ? |
Featured News
NXS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online